624 related articles for article (PubMed ID: 16732216)
1. Penetration of second-, third-, and fourth-generation topical fluoroquinolone into aqueous and vitreous humour in a rabbit endophthalmitis model.
Yağci R; Oflu Y; Dinçel A; Kaya E; Yağci S; Bayar B; Duman S; Bozkurt A
Eye (Lond); 2007 Jul; 21(7):990-4. PubMed ID: 16732216
[TBL] [Abstract][Full Text] [Related]
2. The effect of cataract surgery on ocular levels of topical moxifloxacin.
Mather R; Stewart JM; Prabriputaloong T; Wong J; McLeod SD
Am J Ophthalmol; 2004 Oct; 138(4):554-9. PubMed ID: 15488780
[TBL] [Abstract][Full Text] [Related]
3. Ocular pharmacokinetics of moxifloxacin after topical treatment of animals and humans.
Robertson SM; Curtis MA; Schlech BA; Rusinko A; Owen GR; Dembinska O; Liao J; Dahlin DC
Surv Ophthalmol; 2005 Nov; 50 Suppl 1():S32-45. PubMed ID: 16257309
[TBL] [Abstract][Full Text] [Related]
4. Ocular penetration of levofloxacin, ofloxacin and ciprofloxacin in eyes with functioning filtering blebs: investigator masked, randomised clinical trial.
Cantor LB; WuDunn D; Yung CW; Valluri S; Catoira YP; Hoop JS; Morgan LS
Br J Ophthalmol; 2008 Mar; 92(3):345-7. PubMed ID: 18211932
[TBL] [Abstract][Full Text] [Related]
5. Fourth-generation fluoroquinolone penetration into the aqueous humor in humans.
McCulley JP; Caudle D; Aronowicz JD; Shine WE
Ophthalmology; 2006 Jun; 113(6):955-9. PubMed ID: 16603244
[TBL] [Abstract][Full Text] [Related]
6. Differential aqueous and vitreous concentrations of moxifloxacin and ofloxacin after topical administration one hour before vitrectomy.
Lai WW; Chu KO; Chan KP; Choy KW; Wang CC; Tsang CW; Pang CP
Am J Ophthalmol; 2007 Aug; 144(2):315-8. PubMed ID: 17659971
[TBL] [Abstract][Full Text] [Related]
7. Determination of aqueous and vitreous concentration of moxifloxacin 0.5% after delivery via a dissolvable corneal collagen shield device.
Hariprasad SM; Shah GK; Chi J; Prince RA
J Cataract Refract Surg; 2005 Nov; 31(11):2142-6. PubMed ID: 16412929
[TBL] [Abstract][Full Text] [Related]
8. Comparative intraocular penetration of 4 fluoroquinolones after topical instillation.
Chung JL; Lim EH; Song SW; Kim BY; Lee JH; Mah FS; Seo KY
Cornea; 2013 Jul; 32(7):1046-51. PubMed ID: 23615274
[TBL] [Abstract][Full Text] [Related]
9. Vitreous and aqueous penetration of orally and topically administered moxifloxacin.
Fukuda M; Shibata N; Osada H; Yamashiro Y; Sasaki H
Ophthalmic Res; 2011; 46(3):113-7. PubMed ID: 21325873
[TBL] [Abstract][Full Text] [Related]
10. A comparison of moxifloxacin and levofloxacin topical prophylaxis in a fluoroquinolone-resistant Staphylococcus aureus rabbit model.
Kowalski RP; Romanowski EG; Mah FS; Sasaki H; Fukuda M; Gordon YJ
Jpn J Ophthalmol; 2008; 52(3):211-216. PubMed ID: 18661272
[TBL] [Abstract][Full Text] [Related]
11. Human intraocular penetration pharmacokinetics of moxifloxacin 0.5% via topical and collagen shield routes of administration.
Hariprasad SM; Mieler WE; Shah GK; Blinder KJ; Apte RS; Holekamp NM; Thomas MA; Chi J; Prince RA
Trans Am Ophthalmol Soc; 2004; 102():149-55; discussion 155-7. PubMed ID: 15747753
[TBL] [Abstract][Full Text] [Related]
12. Comparative penetration of moxifloxacin and gatifloxacin in rabbit aqueous humor after topical dosing.
Levine JM; Noecker RJ; Lane LC; Herrygers L; Nix D; Snyder RW
J Cataract Refract Surg; 2004 Oct; 30(10):2177-82. PubMed ID: 15474833
[TBL] [Abstract][Full Text] [Related]
13. Vitreous and aqueous penetration of orally administered moxifloxacin in humans.
Vedantham V; Lalitha P; Velpandian T; Ghose S; Mahalakshmi R; Ramasamy K
Eye (Lond); 2006 Nov; 20(11):1273-8. PubMed ID: 16200061
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of intravenously administered moxifloxacin in eye compartments: an experimental study.
Tzepi I; Vergados I; Kanellakopoulou K; Papathanassiou M; Kranidioti H; Tsaganos T; Liarakos V; Giamarellos-Bourboulis EJ; Theodossiadis P
Int J Antimicrob Agents; 2009 Feb; 33(2):160-2. PubMed ID: 18947985
[TBL] [Abstract][Full Text] [Related]
15. Ocular pharmacokinetics, safety and efficacy of intracameral moxifloxacin 0.5% solution in a rabbit model.
Asena L; Akova YA; Goktaş MT; Bozkurt A; Yaşar U; Karabay G; Demiralay E
Curr Eye Res; 2013 Apr; 38(4):472-9. PubMed ID: 23373761
[TBL] [Abstract][Full Text] [Related]
16. Clearance of intravitreal moxifloxacin.
Iyer MN; He F; Wensel TG; Mieler WF; Benz MS; Holz ER
Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):317-9. PubMed ID: 16384979
[TBL] [Abstract][Full Text] [Related]
17. Bactericidal effect of intravitreal levofloxacin in an experimental model of endophthalmitis.
Ferrer C; Rodríguez A; Abad JL; Fernandez J; Alió JL
Br J Ophthalmol; 2008 May; 92(5):678-82. PubMed ID: 18211926
[TBL] [Abstract][Full Text] [Related]
18. Comparison of corneal and aqueous humor penetration of moxifloxacin, gatifloxacin and levofloxacin during keratoplasty.
Fukuda M; Yamada M; Kinoshita S; Inatomi T; Ohashi Y; Uno T; Shimazaki J; Satake Y; Maeda N; Hori Y; Nishida K; Kubota A; Nakazawa T; Shimomura Y
Adv Ther; 2012 Apr; 29(4):339-49. PubMed ID: 22529026
[TBL] [Abstract][Full Text] [Related]
19. Aqueous humour penetration of moxifloxocin and gatifloxacin eye drops in different dosing regimens before phacoemulsification surgery.
Güngör SG; Akova YA; Bozkurt A; Yasar Ü; Babaoğlu MÖ; Çetinkaya A; Çolak M
Br J Ophthalmol; 2011 Sep; 95(9):1272-5. PubMed ID: 21030410
[TBL] [Abstract][Full Text] [Related]
20. Vitreous and aqueous penetration of intravitreally and orally administered moxifloxacin in an experimental rabbit model of fungal endophthalmitis.
Arikan S; Ozdek S; Aktas Z; Dinçel A; Hasanreisoglu B
J Pharm Pharmacol; 2013 May; 65(5):659-64. PubMed ID: 23600382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]